Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 15/20 | 0.46 |
| ▸ | TLR8 | Q9NR97 | 10/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15470093 | 0.93 | TLR7 (0.53) | TLR7TLR8CYP1A2L3MBTL1CYP2D6 | |
| SCHEMBL23472451 | 0.85 | TLR7 (0.51) | TLR7TLR8CYP1A2L3MBTL1CYP2D6 | |
| SCHEMBL20219358 | 0.84 | CYP3A4 (0.41) | TLR7TLR8CYP1A2CYP2D6 | |
| SCHEMBL13195677 | 0.83 | TLR7 (0.49) | TLR7TLR8CYP1A2L3MBTL1CYP2D6 | |
| SCHEMBL15470024 | 0.83 | TLR7 (0.51) | TLR7TLR8CYP1A2L3MBTL1CYP2D6 | |
| SCHEMBL15470063 | 0.83 | TLR7 (0.61) | TLR7TLR8CYP1A2L3MBTL1CYP2D6 | |
| SCHEMBL15469981 | 0.83 | TLR7 (0.49) | TLR7TLR8CYP1A2L3MBTL1CYP2D6 | |
| SCHEMBL20219387 | 0.82 | CYP1A2 (0.45) | TLR7TLR8CYP1A2L3MBTL1CYP2D6 | |
| SCHEMBL23472284 | 0.82 | TLR7 (0.50) | TLR7TLR8CYP1A2L3MBTL1CYP2D6 | |
| SCHEMBL13195051 | 0.81 | TLR7 (0.68) | TLR7TLR8CYP1A2L3MBTL1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3590928-B1 | PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS | JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) | 2021-06-09 | — | — | EP | disclosed |
| EP-3330257-A1 | PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS | Janssen Sciences Ireland UC (IE) | 2018-06-06 | — | — | EP | disclosed |